Literature DB >> 1471232

Plasma glutathione level in paracetamol daily abuser patients. Changes in plasma cysteine and thiol groups after reduced glutathione administration.

T Trenti1, M Bertolotti, C N Castellana, A Ferrari, L A Pini, E Sternieri.   

Abstract

Since plasma reduced glutathione (GSH) seems to reflect liver GSH content, we have assessed plasma GSH in patients using paracetamol daily. In these patients a significant lower plasma GSH concentration was found with respect to controls. After the i.v. administration of GSH free plasma cysteine was 12 fold higher than in basal condition and all the pattern of plasma thiol groups was modified. This work suggests that the possible protective effect of GSH administration is due to the availability of plasma thiol compounds that enter the cell rather than GSH itself.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1471232     DOI: 10.1016/0378-4274(92)90258-l

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  4 in total

1.  Acquired 5-oxoproline acidemia successfully treated with N-acetylcysteine.

Authors:  Gregory L Hundemer; Andrew Z Fenves
Journal:  Proc (Bayl Univ Med Cent)       Date:  2017-04

2.  5-Oxoproline (pyroglutamic) acidosis associated with chronic acetaminophen use.

Authors:  Jennifer L Duewall; Andrew Z Fenves; Daniel S Richey; Long D Tran; Michael Emmett
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-01

3.  Therapeutic paracetamol treatment in older persons induces dietary and metabolic modifications related to sulfur amino acids.

Authors:  Estelle Pujos-Guillot; Gisèle Pickering; Bernard Lyan; Gilles Ducheix; Marion Brandolini-Bunlon; Françoise Glomot; Dominique Dardevet; Claude Dubray; Isabelle Papet
Journal:  Age (Dordr)       Date:  2011-02-22

4.  Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.

Authors:  Julie Massart; Karima Begriche; Caroline Moreau; Bernard Fromenty
Journal:  J Clin Transl Res       Date:  2017-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.